Balancing Safety and Access in Psychedelic Regulation

A national perspective on Alberta’s new Psychedelic Drug Treatment Services framework — balancing safety, accessibility, and innovation.

Developed collaboratively by MAPS Canada with co-author Reverdi Darda, RN, BScN, CHE, this position paper examines Alberta’s pioneering psychedelic drug treatment regulation — the first of its kind in Canada.

The document provides a balanced, evidence-based analysis of how new provincial standards can ensure safety without restricting access for patients who could benefit from psychedelic-assisted therapies.

It offers practical recommendations to improve equity, workforce capacity, and quality of care in the evolving field of psychedelic medicine.

MAPS Canada’s Response to Alberta's Psychedelic Drug Treatment Services Regulation and Service Standards

Download the Full Report

BALANCING SAFETY AND ACCESS: MAPS Canada’s Response to Alberta's Psychedelic Drug Treatment Services Regulation and Service Standards

Receive the full 14-page MAPS Canada report instantly by email.